Hims & Hers (HIMS) doubles revenue, expands margins, and grows subscribers. Zava acquisition triples market potential, ...

Department of Pharmacology and Molecular Sciences, Johns Hopkins University, Baltimore, United States ...

An osteoanabolic agent should be the first choice treatment for patients at high or imminent risk for fracture, but once ...